Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marion Smits

Showing results (121-130 of 220) with videos related to

Pageof 22
Sort By:
Plos One|July 15, 2015
Quantitative Functional Arterial Spin Labeling (fASL) MRI--Sensitivity and Reproducibility of Regional CBF Changes Using Pseudo-Continuous ASL Product SequencesRebecca M E Steketee, Henri J M M Mutsaerts, Esther E Bron, et al.
Magma (New York, N.Y.)|February 19, 2021
Mapping tumour heterogeneity with pulsed 3D CEST MRI in non-enhancing glioma at 3 TEsther A H Warnert, Tobias C Wood, Fatih Incekara, et al.
Insights Into Imaging|June 9, 2026
Toward a standardized and interoperable imaging biomarker catalogPablo Rodríguez-Belenguer, Paula Doria-Borrell, Ángel Alberich-Bayarri, et al.
Human Brain Mapping|April 5, 2014
Diagnostic classification of arterial spin labeling and structural MRI in presenile early stage dementiaEsther E Bron, Rebecca M E Steketee, Gavin C Houston, et al.
Plos One|August 5, 2014
Inter-vendor reproducibility of pseudo-continuous arterial spin labeling at 3 TeslaHenri J M M Mutsaerts, Rebecca M E Steketee, Dennis F R Heijtel, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 21, 2024
[<sup>18</sup>F]FET PET/MRI: An Accurate Technique for Detection of Small Functional Pituitary TumorsIlanah J Pruis, Frederik A Verburg, Rutger K Balvers, et al.
Magma (New York, N.Y.)|January 16, 2015
Reproducibility of pharmacological ASL using sequences from different vendors: implications for multicenter drug studiesHenri J M M Mutsaerts, Rebecca M E Steketee, Dennis F R Heijtel, et al.
Neuro-Oncology|March 29, 2018
The T2-FLAIR mismatch sign as an imaging marker for non-enhancing IDH-mutant, 1p/19q-intact lower-grade glioma: a validation studyMartinus P G Broen, Marion Smits, Maarten M J Wijnenga, et al.
NMR in Biomedicine|December 12, 2024
The Road to a Realistic 3D Model for Estimating R<sub>2</sub> and R<sub>2</sub>* Relaxation Versus Gd-DTPA Concentration in Whole Blood and Brain Tumor VasculatureDaniëlle van Dorth, Ahmad Alafandi, Sadaf Soloukey, et al.
NMR in Biomedicine|April 24, 2024
Influence of arterial transit time delays on the differentiation between tumor progression and pseudoprogression in glioblastoma by arterial spin labeling magnetic resonance imagingDaniëlle van Dorth, Feng Yan Jiang, Bárbara Schmitz-Abecassis, et al.
Pageof 22

Showing results (121-130 of 220) with videos related to

Sort By:
Pageof 22
Plos One|July 15, 2015
Quantitative Functional Arterial Spin Labeling (fASL) MRI--Sensitivity and Reproducibility of Regional CBF Changes Using Pseudo-Continuous ASL Product SequencesRebecca M E Steketee, Henri J M M Mutsaerts, Esther E Bron, et al.
Magma (New York, N.Y.)|February 19, 2021
Mapping tumour heterogeneity with pulsed 3D CEST MRI in non-enhancing glioma at 3 TEsther A H Warnert, Tobias C Wood, Fatih Incekara, et al.
Insights Into Imaging|June 9, 2026
Toward a standardized and interoperable imaging biomarker catalogPablo Rodríguez-Belenguer, Paula Doria-Borrell, Ángel Alberich-Bayarri, et al.
Human Brain Mapping|April 5, 2014
Diagnostic classification of arterial spin labeling and structural MRI in presenile early stage dementiaEsther E Bron, Rebecca M E Steketee, Gavin C Houston, et al.
Plos One|August 5, 2014
Inter-vendor reproducibility of pseudo-continuous arterial spin labeling at 3 TeslaHenri J M M Mutsaerts, Rebecca M E Steketee, Dennis F R Heijtel, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 21, 2024
[<sup>18</sup>F]FET PET/MRI: An Accurate Technique for Detection of Small Functional Pituitary TumorsIlanah J Pruis, Frederik A Verburg, Rutger K Balvers, et al.
Magma (New York, N.Y.)|January 16, 2015
Reproducibility of pharmacological ASL using sequences from different vendors: implications for multicenter drug studiesHenri J M M Mutsaerts, Rebecca M E Steketee, Dennis F R Heijtel, et al.
Neuro-Oncology|March 29, 2018
The T2-FLAIR mismatch sign as an imaging marker for non-enhancing IDH-mutant, 1p/19q-intact lower-grade glioma: a validation studyMartinus P G Broen, Marion Smits, Maarten M J Wijnenga, et al.
NMR in Biomedicine|December 12, 2024
The Road to a Realistic 3D Model for Estimating R<sub>2</sub> and R<sub>2</sub>* Relaxation Versus Gd-DTPA Concentration in Whole Blood and Brain Tumor VasculatureDaniëlle van Dorth, Ahmad Alafandi, Sadaf Soloukey, et al.
NMR in Biomedicine|April 24, 2024
Influence of arterial transit time delays on the differentiation between tumor progression and pseudoprogression in glioblastoma by arterial spin labeling magnetic resonance imagingDaniëlle van Dorth, Feng Yan Jiang, Bárbara Schmitz-Abecassis, et al.
Pageof 22